The mainboard initial public offering (IPO) of New Delhi/Gurugram-headquartered pediatric neurodevelopmental therapy, developmental care centres, and special education healthcare specialist Rays of Be…
The mainboard initial public offering (IPO) of New Delhi/Gurugram-headquartered pediatric neurodevelopmental therapy, developmental care centres, and special education healthcare specialist Rays of Belief Limited (operating under the flagship brand Mom’s Belief) witnessed strong bidding acceleration on its second day of public bidding across national bourses today, Wednesday, September 2, 2026.
Carrying an aggregate issue size of ₹125.00 crore set within an official price band parameter of ₹227.00 to ₹239.00 per share, the public offer represents a 100% fresh primary equity issuance. Proceeds will primarily fund the physical network rollout and fit-outs of 319 new therapy centres across India, technology hardware and therapy inventory investments, US subsidiary centre leases, and general corporate operations.
Building upon its solid Day 1 oversubscription (1.18x), the second trading session saw everyday retail investors and high-net-worth wealth accounts expand their bidding volumes significantly. By the close of trading at 5:00 PM IST across BSE and NSE, central exchange matching registries compiled valid electronic application tokens for 1,13,38,684 equity shares against a net public offer pool of 31,37,810 equity shares (excluding anchor allocations).
This pushed the cumulative Day 2 subscription baseline up to 3.61 times (361% coverage).
Retail individual investors and Non-Institutional Investors (NII / HNI) spearheaded the volume surge, taking their respective quotas to 18.56 times and 2.06 times, while Qualified Institutional Buyers (QIBs) registered token bids at 0.01 times (14,942 shares) ahead of Thursday's final closing bell.
At the upper price band cap of ₹239 per share, the offer has mobilized an aggregate primary capital demand value of ₹270.99 crore clearing through central registries.
The multi-day public bidding window will officially close tomorrow, Thursday, September 3, 2026.
Here is an extended, plain-English breakdown covering Day 2 subscription metrics, unlisted grey market trends, business operations across neurodevelopmental disorder (NDD) therapies and developmental clinics, financial performance, capex deployment plans, valuation parameters, and the upcoming allotment schedule.
1. Day 2 Subscription Data Breakdown
By 5:00 PM on Day 2, central exchange processing registries compiled total valid application orders worth ₹270.99 crore (calculated at the upper price band cap of ₹239 per share), covering 361% of the net public offer.
The table below summarizes the second day's performance across all investor categories:
+-----------------------------------------------------------------------------------+ | RAYS OF BELIEF LIMITED: DAY 2 SUBSCRIPTION DATA | +-------------------+-----------------+------------------+------------------+-------+ | Category | Shares Offered | Shares Bid For | Subscription (x) | Value | +-------------------+-----------------+------------------+------------------+-------+ | QIB (Institutions)| 18,30,310 | 14,942 | 0.01x | ₹0.36Cr | NII / HNI (Wealth)| 7,84,500 | 16,18,696 | 2.06x | ₹38.69Cr | Retail (RII) | 5,23,000 | 97,05,046 | 18.56x | ₹231.95Cr +-------------------+-----------------+------------------+------------------+-------+ | Total Net Offer | 31,37,810 | 1,13,38,684 | 3.61x | ₹270.99Cr +-------------------+-----------------+------------------+------------------+-------+
(Source: BSE/NSE Consolidated Bidding Platform Data)
Analyzing the Category Inflows:
- Retail Individual Investors (RII - 18.56x): Everyday retail accounts expanded their bids nearly threefold from Day 1 (34.05 lakh shares) to reach 97,05,046 shares (1,56,533 application lots) worth ₹231.95 crore against 5.23 lakh shares reserved for them, pushing retail coverage to a stellar 18.56 times. The minimum retail application lot is fixed at 62 shares, requiring an accessible baseline layout of ₹14,818 at ₹239 per share.
- Non-Institutional Investors (NII / HNI - 2.06x): High-net-worth wealth accounts, corporate treasuries, and family offices increased their bids by more than 5x from 3.06 lakh shares on Day 1 to 16,18,696 shares worth ₹38.69 crore against 7.85 lakh shares offered, taking HNI coverage to 2.06 times. Both small-HNI (minimum 14 lots / 868 shares = ₹2,07,452) and big-HNI brackets recorded active participation.
- Qualified Institutional Buyers (QIB - 0.01x): Institutional desks stepped up bids slightly from 868 shares on Day 1 to 14,942 shares worth ₹35.71 lakh against 18.30 lakh shares offered in their net allocation slice. Under standard mainboard book-building guidelines, institutional funds traditionally deploy the bulk of their large block orders on the final afternoon of Day 3.
- Anchor Investor Allocation: Prior to the public open, Rays of Belief raised ₹50.00 crore through its institutional anchor placement on Monday, August 31, 2026, allocating 20,92,190 equity shares at ₹239 per share to 5 marquee institutional anchor investors.
2. Unlisted Grey Market Premium (GMP) & Market Sentiment
In the unofficial grey market, sentiment surrounding Rays of Belief continues to track with solid premium interest:
- Fixed Upper Price Cap Anchor: ₹239.00 per share
- Current Grey Market Premium (GMP): Tracking around +₹38.00 to +₹50.00 per share (~15.9% to 20.9% over issue price)
- Estimated Listing Price Range: Expected debut counter level of ₹277.00 to ₹289.00 per share
- Projected Listing Gain Margin: Indicating an immediate estimated listing upside of ~15.90% to 20.92%
- Retail Application Lot Size: 62 Shares (Minimum Investment: ₹14,818)
What Is Driving Grey Market Optimism?
- Niche Healthcare Moat (Mom’s Belief): Positioned as India's largest specialized developmental care network for children with Autism Spectrum Disorder (ASD), ADHD, Down Syndrome, and learning delays, operating 136 centres across 57 cities and 20 states/UTs alongside 3 US centres.
- Surging Top-Line Scaling (₹82+ Cr in FY26): Revenue expanded from ₹30.76 crore in FY24 to ₹82.06 crore in FY26, with EBITDA reaching ₹11.91 crore (14.59% margin) and operating on a low debt-to-equity ratio of 0.12x.
(Note: Grey market premiums represent informal, off-exchange quotes traded among dealers. They fluctuate based on daily market mood and should not be treated as a guaranteed listing price.)
3. Business Overview: What Does Rays of Belief Do?
Incorporated in 2017 and operating under the widely recognized brand Mom’s Belief, Rays of Belief Limited is an integrated social enterprise and specialized pediatric developmental healthcare provider.
The company delivers personalized clinical and behavioral intervention programs for children aged 18 months to 15 years diagnosed with Neurodevelopmental Disorders (NDDs).
The company's core service suite includes:
- Multidisciplinary Clinical Therapies: Occupational therapy, speech and language pathology, sensory integration, physical therapy, and behavioral interventions.
- Centres Network & Collaboration Models: Company-Owned Learning Centres, Licensed Professional Partnership Centres (partnering with pediatricians and child psychologists), and School Collaboration Centres.
- Digital & Home-Learning Ecosystem: Proprietary child tracking software, over 150 clinic teaching tools, and 2,000+ customized home-learning therapy kits.
- Global Footprint: 136 operational centres across India and 3 wholly-owned international therapy centres in Virginia, USA (Mom's Belief US, Inc.).
+-----------------------------------------------------------------------------------+ | RAYS OF BELIEF BUSINESS AT A GLANCE | +-----------------------------------+-----------------------------------------------+ | Core Brand Platform | Mom's Belief (Pediatric Developmental Care) | +-----------------------------------+-----------------------------------------------+ | Specialization | Autism (ASD), ADHD, Speech Delay, Down Syn. | +-----------------------------------+-----------------------------------------------+ | Active Centre Network | 136 Centres Across 57 Indian Cities + 3 in USA| +-----------------------------------+-----------------------------------------------+ | Clinical Workforce | 340+ Certified Clinical Professionals | +-----------------------------------+-----------------------------------------------+ | Children Impacted | Upwards of 56,500+ Children Since Inception | +-----------------------------------+-----------------------------------------------+ | Lead Manager (BRLM) | Mefcom Capital Markets Limited | +-----------------------------------+-----------------------------------------------+ | Registrar to the Issue | KFin Technologies Limited | +-----------------------------------+-----------------------------------------------+
(Source: Company Red Herring Prospectus)
Core Competitive Moats:
1. First-Mover Advantage in Organized NDD Healthcare
The Indian pediatric developmental therapy market remains highly unorganized. Mom's Belief is the largest institutional chain providing standardized clinical protocols, multi-therapy integration, and parent coaching under one roof.
2. Asset-Light Partnership Expansion Model
By partnering with independent clinics, child psychologists, and schools, the company expands its physical footprint across Tier-2 and Tier-3 cities with minimal upfront real estate capex.
3. 100% Fresh Issue Primary Rollout
Allocating IPO capital directly into 319 new centre fit-outs, clinic hardware, and therapy technology provides visibility for multi-year revenue compounding.
4. Detailed Financial Performance (FY24 to FY26)
An audit of the company's restated financial statements shows rapid revenue expansion and sustained operational profitability over the last three fiscal years.
+-----------------------------------------------------------------------------------+ | RAYS OF BELIEF: 3-YEAR FINANCIAL PERFORMANCE | +-------------------------------+-------------------+-------------------+-----------+ | Financial Metric (₹ in Cr) | FY24 | FY25 | FY26 | +-------------------------------+-------------------+-------------------+-----------+ | Revenue from Operations | 30.61 | 36.42 | 81.66 | | Total Income | 30.76 | 36.54 | 82.06 | | Operating EBITDA | 1.49 | 3.02 | 11.91 | | EBITDA Margin (%) | 4.87% | 8.28% | 14.59% | | Net Profit After Tax (PAT) | 0.85 | 5.88 | 4.96 | | PAT Margin (%) | 2.79% | 16.15% | 6.07% | | Net Worth | 5.78 | 15.02 | 23.76 | | Return on Equity (ROE %) | 16.83% | 56.56% | 21.64% | | Return on Capital Employed % | N/A | 7.49% | 29.74% | | Debt-to-Equity Ratio (x) | N/A | 0.29x | 0.12x | +-------------------------------+-------------------+-------------------+-----------+
(Source: Restated Financial Statements in Prospectus & KPI Reports)
Key Financial Observations:
- Massive Revenue Scaling (167% 2-Year Growth): Total income expanded from ₹30.76 crore in FY24 to ₹36.54 crore in FY25, before jumping 124.6% YoY to ₹82.06 crore in FY26, driven by new centre additions and strong therapy session demand.
- Expanding Operating EBITDA (~14.6%): Operating EBITDA grew to ₹11.91 crore in FY26 (an eightfold expansion over FY24's ₹1.49 crore), with EBITDA margins reaching 14.59% due to higher clinical utilization per centre.
- Consistent Profitability: Net profit after tax (PAT) stood at ₹4.96 crore in FY26 (delivering a 6.07% PAT margin), while FY25 PAT included deferred tax adjustments.
- Improving Capital Efficiency & Low Leverage: The company delivered a Return on Capital Employed (ROCE) of 29.74% and an ROE of 21.64% in FY26, operating with a very low debt-to-equity ratio of 0.12x.
5. Structure of the Offer & Objects of the Issue
The ₹125.00 crore public issue is structured entirely as a fresh primary capital issuance:
+-----------------------------------------------------------------------------------+ | IPO CAPITAL STRUCTURE BREAKDOWN | +-----------------------------------+-----------------------------------------------+ | Total Issue Size | ₹125.00 Crore (52,30,000 Equity Shares) | +-----------------------------------+-----------------------------------------------+ | Fresh Issue Component | ₹125.00 Crore (100% Fresh Capital Issue) | +-----------------------------------+-----------------------------------------------+ | Offer for Sale (OFS) Component | ₹0.00 (No Selling Shareholders) | +-----------------------------------+-----------------------------------------------+ | Price Band | ₹227.00 to ₹239.00 per share | +-----------------------------------+-----------------------------------------------+ | Face Value | ₹10 per share | +-----------------------------------+-----------------------------------------------+ | Anchor Investor Allocation | 20,92,190 Shares (₹50.00 Crore Value) | +-----------------------------------+-----------------------------------------------+ | Net Offer to Public | 31,37,810 Shares (₹75.00 Crore Value) | +-----------------------------------+-----------------------------------------------+ | Lead Manager (BRLM) | Mefcom Capital Markets Limited | +-----------------------------------+-----------------------------------------------+ | Registrar to the Issue | KFin Technologies Limited | +-----------------------------------+-----------------------------------------------+
(Source: Official Red Herring Prospectus)
How Will Fresh Primary Capital Be Deployed?
Because there is no Offer for Sale (OFS), 100% of the proceeds move directly onto the company balance sheet:
- Establishment of New Therapy Centres (₹41.36 Crore / 33.1%): Funding the rollout, fit-outs, and technology hardware for 319 new therapy and developmental centres across India.
- Lease Payments for Existing Indian Centres (₹14.45 Crore / 11.6%): Meeting operational lease obligations across its domestic centre network.
- Investment in US Subsidiary (₹10.13 Crore / 8.1%): Funding lease and operational expansion for Mom's Belief US, Inc. in Virginia.
- General Corporate Purposes & Issue Expenses (₹59.06 Crore / 47.2%): Supporting brand marketing, clinical software development, and working capital needs.
6. Valuation Analysis & Peer Group Comparison
At the upper price band cap of ₹239 per share, Rays of Belief commands a post-issue corporate market capitalization of approximately ₹499.55 crore (based on post-issue equity share capital of 2,09,01,682 shares).
Because there are no directly comparable pure-play listed neurodevelopmental healthcare therapy chains in India, we evaluate the company alongside listed specialized healthcare service providers and hospital chains:
+-----------------------------------------------------------------------------------+ | PEER GROUP VALUATION COMPARISON | +-----------------------------------+--------------------+--------------------------+ | Company Name | Trailing P/E (x) | Primary Focus / Model | +-----------------------------------+--------------------+--------------------------+ | Rays of Belief (At ₹239) | ~100.7x (Post-IPO) | Pediatric NDD Therapy | | Rainbow Children's Medicare Ltd | ~56.40x | Pediatric & Maternity | | Aster DM Healthcare Ltd | ~48.20x | Multi-Specialty Hospital | | KIMS Hospitals Ltd | ~52.80x | Tertiary Care Hospitals | | Yatharth Hospital Ltd | ~38.60x | Multi-Specialty Hospital | +-----------------------------------+--------------------+--------------------------+
Valuation Summary:
At ~100.7x post-issue FY26 trailing earnings (and ~6.1x Price-to-Sales), Rays of Belief is priced at a growth-stage premium reflecting its unique position as India's premier organized developmental therapy platform.
With 124%+ top-line growth in FY26, high ROE (21.64%), near-zero debt (0.12x D/E), and ₹125 crore deployed directly into expanding the physical clinic network from 136 to over 450+ centres, the unique social impact and specialized healthcare story catalyzed the 18.56x retail oversubscription and healthy grey market premium (+₹38–₹50).
7. Core Strengths vs. Key Business Risks
Investors evaluating this mainboard pediatric healthcare issue should consider the following operational factors:
Key Strengths:
- Niche Category Leader: Operates Mom's Belief, the largest organized network for Autism, ADHD, and pediatric developmental delays in India.
- 100% Fresh Issue Deployment: ₹125 crore fresh equity directly funds opening 319 new therapy centres and scaling technology.
- Accelerating Retail & HNI Bidding: Retail jumped to 18.56x and HNIs touched 2.06x on Day 2 as total demand crossed ₹270 crore.
- Asset-Light & Low Debt: Operates with a minimal debt-to-equity ratio of 0.12x and an ROCE of 29.74%.
Key Risk Factors:
- Premium Growth Valuation: Priced at ~100.7x FY26 trailing P/E, requiring execution on its aggressive 319-centre expansion roadmap.
- Talent Dependency: Scalability relies heavily on hiring, training, and retaining qualified speech therapists, occupational therapists, and clinical psychologists.
- Negative Operating Cash Flow: Reported negative operating cash flows in FY26 due to aggressive centre rollout and inventory build-up.
8. Application Matrix & Final Timeline
With the bidding window closing tomorrow, here is the upcoming schedule and application size breakdown:
- Public Bidding Window Closes: Thursday, September 3, 2026 (5:00 PM IST)
- Basis of Allotment Finalization: Friday, September 4, 2026
- Refund Initiations & Unblocking of Bank Funds: Monday, September 7, 2026
- Credit of Equity Shares to Demat Accounts: Monday, September 7, 2026
- Official Stock Exchange Listing (BSE & NSE): Tuesday, September 8, 2026
- Designated Lead Manager: Mefcom Capital Markets Limited
- Designated Registrar: KFin Technologies Limited
Application Size Matrix:
- Retail Minimum: 1 Lot (62 Shares) — ₹14,818
- Retail Maximum: 13 Lots (806 Shares) — ₹1,92,634
- Small HNI (sNII) Minimum: 14 Lots (868 Shares) — ₹2,07,452
- Big HNI (bNII) Minimum: 68 Lots (4,216 Shares) — ₹10,07,624
How to Check Your Allotment Status:
When allotment details go live on Friday, September 4, 2026, applicants can check their status by entering their PAN card number or Application ID on the KFin Technologies Portal or directly on the official BSE/NSE websites under the issue allotment sections.
Conclusion: What Should You Watch for on the Final Day?
Rays of Belief presents a high-growth pediatric neurodevelopmental healthcare and therapy story backed by Mom's Belief brand equity, 136 active centres, ₹82+ crore in revenue scale, and a 100% fresh issue dedicated to opening 319 new centres.
With Day 2 subscription climbing to 3.61x overall (driven by 18.56x retail demand and 2.06x HNI coverage), total primary demand has crossed ₹270 crore.
Over the final trading session on Thursday, watch how institutional QIBs and late-stage wealth accounts deploy their large block orders ahead of the 5:00 PM closing deadline.
Post Excerpt
A complete Day 2 analysis of the ₹125.00 crore Rays of Belief Ltd (Mom's Belief) IPO. Bids jumped to 3.61x on Day 2 with retail leaping to 18.56x and HNIs crossing 2.06x as total primary demand crossed ₹270 crore. Read our full review of company financials (₹82+ Cr revenue, ₹4.96 Cr PAT), Autism and ADHD developmental therapy moats, grey market trends (+₹38–₹50), 319 new centre rollout capex, and valuation ahead of tomorrow's close.
